Eisai's Commitment To Oncology Demonstrated By Clinical Data To Be Presented At ASCO Annual Meeting
LONDON, May 16 /PRNewswire/ -- Eisai Europe Ltd announced today that results from 9 clinical data abstracts about compounds in the company's oncology pipeline, product portfolio and preclinical oncology research have been accepted for presentation at the 44th Annual Meeting of the American Society of Clinical Oncology (ASCO), taking place in Chicag
Source: science20.com